Medication Tapering and Withdrawal· 29 min read
Gabapentin Withdrawal: Symptoms, Timeline, and How to Taper Safely
Coming Off Gabapentin: What to Expect
Updated October 2026. Label facts are from the Neurontin, Gralise, Horizant, Lyrica and Lyrica CR prescribing information.
Gabapentin withdrawal is a group of symptoms, such as anxiety, trouble sleeping, sweating and pain, that can appear when you lower or stop gabapentin after regular use. Gabapentin is the generic name for Neurontin. Gralise is a once-daily form, and Horizant is a related drug that the body turns into gabapentin (Neurontin prescribing information; Gralise and Horizant prescribing information).
I’m a board-certified psychiatrist practicing in North Carolina, and I supervise gabapentin and pregabalin (Lyrica) tapers.
Don’t stop gabapentin suddenly or cut the dose on your own. The label warns that stopping gabapentin abruptly can increase the risk of seizures, and it lists seizures among the reactions reported after people stopped gabapentin (Neurontin prescribing information).
The Neurontin, Gralise, Lyrica and Lyrica CR labels give the same rule: lower or stop the dose gradually over a minimum of 1 week. The Neurontin label adds that a longer period may be needed (Neurontin prescribing information).
Gabapentin Withdrawal at a Glance
- The label says withdrawal symptoms usually start within 48 hours of stopping (Neurontin prescribing information). A review of 18 published case reports and case series found onset from 12 hours to 7 days (Mersfelder and Nichols, 2016).
- Symptoms reported on the label include anxiety, insomnia, agitation, confusion, sweating, nausea, pain, tremor, headache and dizziness. Seizures have also been reported (Neurontin prescribing information).
- No study has measured how often gabapentin withdrawal happens or how long it lasts without treatment. What’s known comes from the label and from case reports.
- A 2023 review found only 4 studies that tested ways to help people come off gabapentin or pregabalin (Anderson et al., 2023).
- Pregabalin (Lyrica) is a Schedule V controlled substance, and gabapentin isn’t a federally controlled substance (Lyrica prescribing information; Neurontin prescribing information).
- Iron (when iron stores are low) and an oral lavender oil called Silexan have the best trial evidence among supplements for symptoms a taper can bring. Magnesium can lower how much gabapentin you absorb (Yagi et al., 2012).
My page on supervised tapering in North Carolina explains how a taper with me works.
Table of Contents
Why Gabapentin Withdrawal Happens
Gabapentin binds to the alpha-2-delta subunit of calcium channels on nerve cells. The label says gabapentin is related in structure to the brain chemical GABA but has no effect on GABA binding, uptake or breakdown. How it eases pain and seizures isn’t known (Neurontin prescribing information).
In April 2025, the Neurontin label updated its warning about stopping gabapentin. It now says withdrawal symptoms have been seen after both short-term and long-term treatment (Neurontin prescribing information).
Gabapentin leaves the body quickly. The label gives a half-life of 5 to 7 hours (Neurontin prescribing information). With a half-life that short, blood levels fall within a day of the last dose.
Absorption also changes with the dose. The label reports that about 60% of a dose is absorbed at 900 mg a day and about 27% at 4,800 mg a day (Neurontin prescribing information). Because of this, the same mg cut doesn’t change blood levels by the same amount at every dose. No study has tested what that means for a taper.
Withdrawal is a sign of physical dependence, and physical dependence and addiction are separate problems. A 2017 systematic review of 106 studies found only 4 published cases of addiction-type behavior in people with no past substance use problem (Bonnet and Scherbaum, 2017).
The same review found that people with a current or past substance use disorder, mostly involving opioids, are the main group at risk of addiction (Bonnet and Scherbaum, 2017). A separate 2017 review found gabapentinoid misuse in 1.6% of the general population and in 3% to 68% of people who misuse opioids (Evoy et al., 2017).
Gabapentin withdrawal can look like benzodiazepine withdrawal. One case report notes that published gabapentin withdrawal symptoms mimic alcohol and benzodiazepine withdrawal (Tran et al., 2005). My guide to Klonopin withdrawal covers the benzodiazepine side.
Gabapentin Withdrawal Symptoms
The label lists the reactions reported after people stopped gabapentin. They include seizures, depression, suicidal thoughts and behavior, agitation, confusion, disorientation, psychotic symptoms, anxiety, insomnia, nausea, pain, sweating, tremor, headache, dizziness and malaise (Neurontin prescribing information).
Case reports add akathisia, an inner restlessness with constant movement (See et al., 2011). In one case after a 1-week taper, symptoms also included chest pain and high blood pressure (Tran et al., 2005).
The Horizant label, written for restless legs and nerve pain after shingles, also warns that stopping a gabapentinoid abruptly may increase the risk of seizures (Horizant prescribing information). One published case describes status epilepticus, a seizure that doesn’t stop, 2 days after a man with no seizure history ran out of gabapentin. He had taken 8,000 mg a day, far above the label’s dose range (Barrueto et al., 2002).
Rare case reports describe catatonia (Rosebush et al., 1999) and a picture like delirium tremens (Pittenger and Desan, 2007) after gabapentin was stopped.
The label also says suicidal thoughts and behavior have been reported after people stopped gabapentin (Neurontin prescribing information). If you have thoughts of suicide during a taper, call or text 988 and tell your prescriber.
Withdrawal, Rebound, or the Original Problem?
Pain, anxiety, poor sleep or restless legs during a taper can come from withdrawal, from a short rebound, or from the condition gabapentin was treating.
| Pattern | What it looks like |
|---|---|
| Withdrawal | New symptoms such as sweating, tremor, nausea or agitation, usually within 48 hours of stopping (Neurontin prescribing information) |
| Rebound | A short rise in the symptom the drug treated. In a pregabalin trial, rebound anxiety after a 1-week taper was 0% to 6% (Kasper et al., 2014a) |
| Return of the original condition | The pain, anxiety, sleep problem or restless legs that led to treatment comes back. |
If you take gabapentin for sleep, my guide to sleep medications compares the prescription and nonprescription choices. If you take it for anxiety, my anxiety treatment in North Carolina page compares the anxiety medicines.
Gabapentin Withdrawal Timeline: How Long Does It Last?
This timeline comes from the label and from published case reports.
| Stage | What to expect |
|---|---|
| Onset | Usually within 48 hours of stopping (Neurontin prescribing information). Case reports range from 12 hours to 7 days (Mersfelder and Nichols, 2016) |
| After a 1-week taper | In one case, symptoms began the day after the last dose and became severe by day 10 (Tran et al., 2005) |
| After restarting gabapentin | In published cases, symptoms settled within 8 hours to 2 days of restarting (See et al., 2011; Tran et al., 2005) |
| Length without treatment | Not measured in any study |
| A very slow taper | One published taper for severe gabapentin dependence took 18 months (Deng et al., 2021) |
The published cases span doses from 400 to 8,000 mg a day and use from 3 weeks to 5 years (See et al., 2011).
Antidepressants can cause withdrawal symptoms too. My guide to antidepressant discontinuation syndrome covers them.
How to Taper Off Gabapentin

The Neurontin label says a dose cut, a stop or a switch to another medicine should happen gradually over a minimum of 1 week. It adds that a longer period may be needed (Neurontin prescribing information). The Gralise label uses the same 1-week minimum (Gralise prescribing information).
The Horizant label has one exception. People who take 600 mg or less once a day for restless legs can stop without a taper. People who take it twice a day for nerve pain after shingles should go to once a day for 1 week before stopping (Horizant prescribing information).
One week is the shortest taper the labels allow. In the 2005 case, a 1-week taper still led to severe withdrawal, and the authors proposed tapering over weeks to months, as with a benzodiazepine (Tran et al., 2005).
UK prescriber guidance notes that a taper slower than the labels’ minimum lets a prescriber see symptoms the drug may have been controlling (Public Health England and NHS England, 2014).
A 2023 scoping review found only 4 studies of ways to help people come off gabapentin or pregabalin, and it couldn’t name a best method (Anderson et al., 2023).
The 2025 benzodiazepine tapering guideline uses steps that get smaller as the dose falls (Brunner et al., 2025). No study has tested that approach for gabapentin.
I plan each gabapentin taper around why you take it, how long you’ve taken it, how earlier dose changes went and what other medications you take. I hold each step until symptoms settle, and I plan the next step at the next visit.
Gabapentin Dose Forms
| Dose form | Strengths | Note |
|---|---|---|
| Neurontin and generic gabapentin capsules | 100, 300 and 400 mg | Swallowed whole (Neurontin prescribing information) |
| Neurontin and generic gabapentin tablets | 600 and 800 mg | Scored, so they can be split in half (Neurontin prescribing information) |
| Gabapentin oral solution | 250 mg per 5 mL | A liquid measured by volume (Neurontin prescribing information) |
| Gralise tablets | 300, 450, 600, 750 and 900 mg | Once a day with the evening meal; not to be split (Gralise prescribing information) |
| Horizant extended-release tablets | 300 and 600 mg | A related drug that the body turns into gabapentin (Horizant prescribing information) |
The 100 mg capsule and the oral solution allow smaller steps than the tablets.
Breathing Risk With Opioids and Alcohol
In 2019, the FDA warned that serious breathing problems can occur with gabapentin or pregabalin. The risk is higher in people who also take opioids or other drugs that depress the central nervous system, in people with lung disease such as COPD, and in older adults (FDA, 2019).
In an Ontario population study, people who took an opioid plus gabapentin had higher odds of opioid-related death than people who took an opioid alone. The adjusted odds ratio was 1.49 (Gomes et al., 2017).
The Lyrica label reports added effects on thinking and coordination when pregabalin is taken with alcohol, lorazepam or oxycodone (Lyrica prescribing information). Tell your prescriber about any opioid, benzodiazepine, sleep medicine or alcohol use before and during a taper.
If you’re in North Carolina and want help planning yours, you can book a free 15-minute consultation.
Pregabalin (Lyrica) Withdrawal
Pregabalin is the generic name for Lyrica and Lyrica CR. The Lyrica label says some people who stopped it abruptly or quickly reported insomnia, nausea, headache, anxiety, heavy sweating and diarrhea. It tells prescribers to taper pregabalin gradually over a minimum of 1 week (Lyrica prescribing information).
The Lyrica CR label, revised in 2025, lists a similar set of reactions after a stop, including seizures, depression and suicidal thoughts and behavior (Lyrica CR prescribing information).
Pregabalin is absorbed differently from gabapentin. At least 90% of each dose is absorbed across the dose range, and blood levels rise in step with the dose. Its half-life is about 6 hours (Lyrica prescribing information).
One trial studied what happens when pregabalin is stopped. Adults with generalized anxiety disorder took pregabalin for 12 or 24 weeks and then tapered over 1 week. Withdrawal scores rose only a little, and rebound anxiety occurred in 0% to 6%.
Pfizer, the maker of Lyrica, sponsored the trial (Kasper et al., 2014a).
Withdrawal can still happen at regular doses. A 2021 report of 3 cases, with a review of 6 earlier ones, described withdrawal at 150 to 600 mg a day (Ishikawa et al., 2021). In one case, withdrawal followed only 2 months of use.
Pregabalin is a Schedule V controlled substance (Lyrica prescribing information). In a study of people who used drugs recreationally, a single 450 mg dose of pregabalin received drug-liking ratings similar to 30 mg of diazepam. In clinical trials, 4% of people on pregabalin reported euphoria, compared with 1% on placebo (Lyrica CR prescribing information).
The 2017 review of addiction risk judged pregabalin somewhat more addictive than gabapentin (Bonnet and Scherbaum, 2017). The United Kingdom made both drugs Class C controlled drugs in April 2019 (Medicines and Healthcare products Regulatory Agency, 2019).
Lyrica comes as capsules from 25 to 300 mg and as an oral solution of 20 mg per mL. Lyrica CR comes as extended-release tablets of 82.5, 165 and 330 mg (Lyrica prescribing information; Lyrica CR prescribing information).
I plan a pregabalin taper the same way I plan a gabapentin taper. The label’s minimum is 1 week, and I plan each step around how you responded to the last one.
Supplements That May Help During a Taper

Several supplements have trial evidence for the symptoms a gabapentin taper can bring, such as anxiety, poor sleep, restless legs, nerve pain and nausea.
As of October 2026, no published study has tested a supplement during gabapentin or pregabalin withdrawal itself. The evidence below comes from trials of the same symptoms in other settings.
The FDA doesn’t approve dietary supplements for safety or effectiveness before they’re sold (FDA, 2022). Each dose below is the dose a trial used.
At visits, I review the supplements you already take for interactions with gabapentin, pregabalin and your other medicines.
The Best Evidence: Iron and Silexan
Iron (for restless legs, when iron is low). Horizant is FDA-approved for restless legs syndrome (Horizant prescribing information). If gabapentin has been treating restless legs, those symptoms can come back as the dose comes down. UK prescriber guidance notes that a gradual taper lets a prescriber see symptoms the drug may have been controlling (Public Health England and NHS England, 2014).
In a Cochrane review of 10 studies with 428 people, iron improved restless legs scores more than placebo, and the certainty of that result was moderate (Trotti and Becker, 2019).
Iron is for people whose iron stores are low. A 2026 JAMA review advises iron when ferritin is 100 ng/mL or lower or transferrin saturation is below 20% (Winkelman and Wipper, 2026). Before I suggest iron for restless legs during a taper, I check ferritin.
Silexan (for anxiety). Silexan is an oral lavender oil capsule. In a 10-week trial of 539 adults with generalized anxiety disorder, anxiety scores fell by half or more in 60.3% of people on 160 mg a day, compared with 37.8% on placebo. Side effects were about as common as on placebo (Kasper et al., 2014b).
The trials used 80 or 160 mg a day. Employees of the maker co-wrote the 539-person trial report and a meta-analysis (Kasper et al., 2014b; Möller et al., 2019). The meta-analysis notes that the results apply only to Silexan.
In the US, Silexan is sold without a prescription as a dietary supplement. Look for Silexan or WS 1265 on the label.
Some Evidence
Melatonin (for falling asleep). A meta-analysis of 19 trials with 1,683 people found that melatonin cut the time to fall asleep by about 7 minutes and added about 8 minutes of sleep (Ferracioli-Oda et al., 2013). A 2022 network meta-analysis in The Lancet found no material overall benefit for melatonin in insomnia disorder (De Crescenzo et al., 2022). I’d treat melatonin as a small help for falling asleep.
Melatonin products vary. In a lab test of 31 supplements, the melatonin content ranged from 83% below to 478% above the amount on the label (Erland and Saxena, 2017).
Ginger (for nausea). In a meta-analysis of 12 trials with 1,278 pregnant women, ginger eased nausea more than placebo but didn’t reduce vomiting. Doses under 1,500 mg a day seemed to work better (Viljoen et al., 2014).
Saffron (for low mood and anxiety). A 2026 meta-analysis of 34 trials with 1,769 adults found lower self-rated depression and anxiety scores with saffron. Clinician-rated scales didn’t change (Mahmoudi et al., 2026).
Omega-3 fish oil (for anxiety and low mood). In a meta-analysis of anxiety trials, omega-3 helped only at 2,000 mg a day or more (Su et al., 2018). For depression, formulas with mostly EPA worked better than formulas with mostly DHA (Liao et al., 2019).
Alpha-lipoic acid (for diabetic nerve symptoms). In a meta-analysis of 10 trials with 1,242 people with diabetic neuropathy, oral alpha-lipoic acid improved overall nerve symptom scores, but pain scores alone didn’t improve (Hsieh et al., 2023).
Palmitoylethanolamide, or PEA (for chronic pain). A meta-analysis of double-blind trials with 774 people found less pain with PEA than with placebo (Lang-Illievich et al., 2023). The effect sizes are large for a supplement, so I’d read them with caution.
Chamomile (for anxiety). In an 8-week trial of 57 adults with generalized anxiety disorder, chamomile extract lowered anxiety scores more than placebo (Amsterdam et al., 2009).
Ashwagandha (for anxiety and stress). A meta-analysis of 12 trials with 1,002 people found lower anxiety and stress scores, with low certainty (Akhgarjand et al., 2022). Ashwagandha has caused liver injury with jaundice 2 to 12 weeks after people started it (Björnsson et al., 2020). If you have liver disease, I’d avoid it.
Vitamin D (for low mood, when vitamin D is low). A meta-analysis of 41 trials with 53,235 adults found that vitamin D lowered depressive symptoms, mainly at 2,000 IU a day or more (Mikola et al., 2023).
When I suggest vitamin D, I pair it with vitamin K2. In a meta-analysis of 8 trials with 971 people, vitamin K given with vitamin D raised bone mineral density more than the comparison groups (Kuang et al., 2020). A 2024 review describes how vitamin K2 activates matrix Gla protein, a protein that helps prevent calcium build-up in blood vessels (Skalny et al., 2024).
If you take warfarin, talk with your prescriber before you take vitamin K. The NIH notes that vitamin K can have a serious interaction with warfarin (NIH Office of Dietary Supplements, 2026b).
Magnesium and Gabapentin
Three small trials in 151 older adults with insomnia found that people fell asleep about 17 minutes faster on magnesium, and the quality of that evidence was low to very low (Mah and Pitre, 2021).
Magnesium can lower the amount of gabapentin your body absorbs. In 13 healthy adults, 1 g of magnesium oxide cut gabapentin absorption by 32% (Yagi et al., 2012). The Neurontin label recommends taking gabapentin at least 2 hours after an antacid that contains magnesium and aluminum hydroxide (Neurontin prescribing information).
I found no published study that tested magnesium glycinate or citrate with gabapentin. Taking gabapentin at least 2 hours after any magnesium product is the cautious choice. During a taper, a drop in absorption on some days can work like an unplanned dose cut.
The Lyrica label lists no antacid interaction for pregabalin (Lyrica prescribing information).
Magnesium can build up when kidney function is low (NIH Office of Dietary Supplements, 2026a). Gabapentin and pregabalin doses are also adjusted for kidney function (Neurontin prescribing information; Lyrica prescribing information).
Weak or Mixed Evidence
| Supplement | What the evidence shows |
|---|---|
| Valerian | In a meta-analysis of 18 trials, the time to fall asleep differed from placebo by less than 1 minute (Fernández-San-Martín et al., 2010) |
| L-theanine | One small trial in healthy adults found lower stress scores and better sleep quality (Hidese et al., 2019) |
| Passionflower | A small pilot trial in generalized anxiety disorder found results similar to oxazepam (Akhondzadeh et al., 2001) |
| Lemon balm | Small trials point to less anxiety and low mood, but the trials differ a lot from each other (Ghazizadeh et al., 2021) |
| Acetyl-L-carnitine | A Cochrane review was very uncertain whether it eases diabetic nerve pain (Rolim et al., 2019) |
| Vitamin B12 | In 90 people with type 2 diabetes on long-term metformin and B12 below 400 pmol/L, 1 year of methylcobalamin improved pain scores and nerve tests compared with placebo (Didangelos et al., 2021) |
| Oral GABA | A review of 14 studies found very limited evidence for sleep (Hepsomali et al., 2020). Gabapentin has no effect on GABA binding, uptake or breakdown (Neurontin prescribing information). |
| CBD | A meta-analysis found too little evidence to guide its use for anxiety (Black et al., 2019) |
| Zinc | In a meta-analysis of trials in people with depression, zinc lowered depression scores, and the authors called for more trials (Yosaee et al., 2022) |
| Curcumin | A network meta-analysis found benefit for depression, mostly as an add-on to an antidepressant (Cheng et al., 2025). Turmeric, the source of curcumin, is one of the supplements now linked to liver injury in the US (Swanson and Fontana, 2026). |
| Inositol | A meta-analysis found no clear benefit for depression or anxiety (Mukai et al., 2014) |
| Tryptophan and 5-HTP | Only 2 small trials were good enough to analyze (Shaw et al., 2002) |
| Glycine | One small study tested glycine in sleep-restricted volunteers (Bannai et al., 2012) |
| N-acetylcysteine (NAC) | A review found only preliminary evidence for NAC in anxiety (Deepmala et al., 2015). No trial has tested NAC in withdrawal. |
| Taurine and magnolia bark | I found no human trials of either one for these symptoms. |
What to Avoid During a Taper
Gabapentin and pregabalin can slow breathing when they’re combined with opioids or other drugs that depress the central nervous system (FDA, 2019). The products below add sedation, liver risk or a dependence of their own.
Kava. In a 16-week trial of 171 adults with generalized anxiety disorder, kava worked no better than placebo, and liver test abnormalities were more common on kava (Sarris et al., 2020). The NIH says kava shouldn’t be combined with other sedating substances (NCCIH, 2025).
Phenibut. In a review of 62 published cases, 86.8% of people got phenibut online. The review found that 48.7% of people with phenibut toxicity needed a breathing tube. Phenibut withdrawal caused anxiety, agitation, insomnia and psychosis (Weleff et al., 2023).
Kratom and 7-OH. The FDA says kratom isn’t lawfully marketed in the U.S. as a dietary supplement. It also says 7-OH, an alkaloid in kratom, acts on mu-opioid receptors more potently than morphine (FDA, 2025b).
Tianeptine. Tianeptine isn’t FDA-approved for any medical use, and the FDA has linked tianeptine products to serious harm, overdoses and death (FDA, 2025a).
Supervised Gabapentin and Pregabalin Tapering in North Carolina
I’m board-certified by the American Board of Psychiatry and Neurology in Psychiatry and Forensic Psychiatry. I plan gabapentin and pregabalin tapers for adults across North Carolina, and my page on supervised tapering in North Carolina explains how it works.
The FDA has approved gabapentin for nerve pain after shingles and as an add-on treatment for partial-onset seizures (Neurontin prescribing information). Pregabalin is also approved for diabetic nerve pain, fibromyalgia and nerve pain after spinal cord injury (Lyrica prescribing information).
If you take either drug for seizures, the clinician who treats your seizures should be part of any dose change. If you take it for pain, the taper plan should account for the pain as well as the withdrawal.
In North Carolina, pregabalin is a Schedule V controlled substance, and pharmacies report gabapentin prescriptions to the state’s Controlled Substances Reporting System (N.C. Gen. Stat. 90-93; N.C. Gen. Stat. 90-113.73).
I see patients by video anywhere in North Carolina, and in person at my Wilmington office by request. A flat $350 a month covers up to two visits. Labs and medications are paid separately, and it’s month to month with no contract.
If you’re taking gabapentin or pregabalin and thinking about coming off, you can start with a free 15-minute consultation.
Frequently Asked Questions
What are the withdrawal symptoms when you stop taking gabapentin?
The label lists anxiety, insomnia, agitation, confusion, sweating, nausea, pain, tremor, headache, dizziness and malaise, along with seizures, depression and suicidal thoughts. Symptoms usually start within 48 hours of stopping.
Why is gabapentin so hard to get off of?
Gabapentin has a short half-life of 5 to 7 hours, so blood levels drop quickly after a dose cut. Withdrawal symptoms also overlap with the pain, anxiety and sleep problems gabapentin often treats. That can make the two hard to tell apart. A 2023 review found only 4 studies on how to taper it.
Can you quit gabapentin cold turkey?
The Neurontin, Gralise and Lyrica labels all call for a gradual taper over a minimum of 1 week. Stopping abruptly can raise the risk of seizures. The one label exception is Horizant at 600 mg or less once a day for restless legs. Plan any change to your dose with your prescriber.
How long does it take to feel normal after stopping gabapentin?
Symptoms usually start within 48 hours of stopping, and case reports describe onset up to 7 days after. No study has measured how long they last without treatment. Your course depends partly on your dose, how long you’ve taken gabapentin and how slowly the dose comes down.
What helps with Lyrica withdrawal symptoms?
A taper slower than the Lyrica label’s 1-week minimum is the first step to plan with your prescriber. No supplement has been tested in pregabalin withdrawal itself. Some have trial evidence for the symptoms a taper can bring, such as Silexan for anxiety and iron for restless legs when iron is low.
Is 100 mg of gabapentin very strong?
100 mg is the smallest Neurontin capsule. For nerve pain after shingles, the label’s dose goes up to 1,800 mg a day. For epilepsy in people 12 and older, the usual dose is 300 to 600 mg three times a day.
Can you have a seizure from stopping gabapentin?
Yes, seizures have been reported. The label warns that stopping gabapentin abruptly can increase the risk of seizures, and it lists seizures among the reactions reported after people stopped gabapentin. One published case describes status epilepticus in a man with no seizure history who ran out of gabapentin at 8,000 mg a day.
Is gabapentin a controlled substance in North Carolina?
Gabapentin isn’t a controlled substance under federal law or North Carolina law. North Carolina pharmacies still report gabapentin prescriptions to the Controlled Substances Reporting System. Pregabalin is a Schedule V controlled substance under federal and North Carolina law.
Does magnesium interact with gabapentin?
Yes, magnesium can lower gabapentin absorption. In a study of 13 healthy adults, magnesium oxide cut gabapentin absorption by 32%. The Neurontin label recommends taking gabapentin at least 2 hours after a magnesium and aluminum antacid. I found no study of other forms of magnesium with gabapentin.
Is gabapentin dependence the same as addiction?
Physical dependence and addiction are separate problems. Withdrawal shows physical dependence. A 2017 review found only 4 published cases of addiction-type behavior in people with no past substance use problem.
Thinking About Coming Off Gabapentin?
I plan slow, supervised gabapentin and pregabalin tapers for adults across North Carolina.
Call (910) 612-6015
This article is for educational purposes and is not medical advice. It does not establish a clinician-patient relationship. Gabapentin and pregabalin tapering requires individual assessment and supervision by a prescriber. Do not start, stop, or change a dose of gabapentin, pregabalin, or any medication without speaking to that prescriber. Stopping these medicines suddenly can cause seizures. Supplements can interact with medicines; review them with your prescriber. If you have a medical emergency, call 911 or go to an emergency room. If you are in crisis, call or text 988, the Suicide and Crisis Lifeline.
References (67)
- Neurontin (gabapentin) capsules, tablets and oral solution. Prescribing information and Medication Guide. Revised 4/2025; DailyMed version effective 12 May 2026. DailyMed
- Gralise (gabapentin) tablets. Prescribing information. DailyMed version effective 30 June 2026. DailyMed
- Horizant (gabapentin enacarbil) extended-release tablets. Prescribing information. Revised 4/2025; DailyMed version effective 28 April 2025. DailyMed
- Lyrica (pregabalin) capsules and oral solution. Prescribing information. Revised 4/2020; DailyMed version effective 15 June 2020. DailyMed
- Lyrica CR (pregabalin) extended-release tablets. Prescribing information. Revised 4/2025; DailyMed version effective 12 March 2026. DailyMed
- U.S. Food and Drug Administration. Neurontin, Gralise, Horizant (gabapentin) and Lyrica, Lyrica CR (pregabalin): Drug Safety Communication, serious breathing problems. 19 December 2019. FDA
- U.S. Food and Drug Administration. FDA 101: Dietary Supplements. Consumer Update, page modified 2 June 2022. FDA
- U.S. Food and Drug Administration. Tianeptine Products Linked to Serious Harm, Overdoses, Death. Consumer Update, 9 May 2025 (cited as FDA, 2025a). FDA
- U.S. Food and Drug Administration. FDA and Kratom. Updated 2 December 2025 (cited as FDA, 2025b). FDA
- NIH Office of Dietary Supplements. Magnesium: Fact Sheet for Health Professionals. Updated 6 January 2026 (cited as 2026a). NIH ODS
- NIH Office of Dietary Supplements. Vitamin K: Fact Sheet for Health Professionals. Updated 22 October 2026 (cited as 2026b). NIH ODS
- National Center for Complementary and Integrative Health. Kava: Usefulness and Safety. Last updated April 2025. NCCIH
- Public Health England and NHS England. Advice for prescribers on the risk of the misuse of pregabalin and gabapentin. December 2014. GOV.UK
- Medicines and Healthcare products Regulatory Agency. Pregabalin (Lyrica), gabapentin (Neurontin) and risk of abuse and dependence: new scheduling requirements from 1 April. Drug Safety Update, 16 April 2019. GOV.UK
- North Carolina General Statutes § 90-93 (Schedule V) and § 90-113.73 (Controlled Substances Reporting System). As posted October 2026. G.S. 90-93; G.S. 90-113.73
- Akhgarjand C, Asoudeh F, Bagheri A, et al. Does Ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2022;36(11):4115-4124. PMID 36017529
- Akhondzadeh S, Naghavi HR, Vazirian M, et al. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. 2001;26(5):363-7. PMID 11679026
- Amsterdam JD, Li Y, Soeller I, et al. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. J Clin Psychopharmacol. 2009;29(4):378-82. PMID 19593179
- Anderson PA, McLachlan AJ, Abdel Shaheed C, et al. Deprescribing interventions for gabapentinoids in adults: A scoping review. Br J Clin Pharmacol. 2023;89(9):2677-2690. PMID 37221314
- Bannai M, Kawai N, Ono K, et al. The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers. Front Neurol. 2012;3:61. PMID 22529837
- Barrueto F, Green J, Howland MA, et al. Gabapentin withdrawal presenting as status epilepticus. J Toxicol Clin Toxicol. 2002;40(7):925-8. PMID 12507063
- Björnsson HK, Björnsson ES, Avula B, et al. Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network. Liver Int. 2020;40(4):825-829. PMID 31991029
- Black N, Stockings E, Campbell G, et al. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis. Lancet Psychiatry. 2019;6(12):995-1010. PMID 31672337
- Bonnet U, Scherbaum N. How addictive are gabapentin and pregabalin? A systematic review. Eur Neuropsychopharmacol. 2017;27(12):1185-1215. PMID 28988943
- Brunner E, Chen CA, Klein T, et al. Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits. J Gen Intern Med. 2025;40(12):2814-2859. PMID 40526204
- Cheng YC, Huang WL, Chen WY, et al. Comparative efficacy and tolerability of nutraceuticals for depressive disorder: A systematic review and network meta-analysis. Psychol Med. 2025;55:e134. PMID 40314175
- De Crescenzo F, D’Alò GL, Ostinelli EG, et al. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis. Lancet. 2022;400(10347):170-184. PMID 35843245
- Deepmala, Slattery J, Kumar N, et al. Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review. Neurosci Biobehav Rev. 2015;55:294-321. PMID 25957927
- Deng H, Benhamou OM, Lembke A. Gabapentin dependence and withdrawal requiring an 18-month taper in a patient with alcohol use disorder: a case report. J Addict Dis. 2021;39(4):575-578. PMID 33783336
- Didangelos T, Karlafti E, Kotzakioulafi E, et al. Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2021;13(2):395. PMID 33513879
- Erland LA, Saxena PK. Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content. J Clin Sleep Med. 2017;13(2):275-281. PMID 27855744
- Evoy KE, Morrison MD, Saklad SR. Abuse and Misuse of Pregabalin and Gabapentin. Drugs. 2017;77(4):403-426. PMID 28144823
- Fernández-San-Martín MI, Masa-Font R, Palacios-Soler L, et al. Effectiveness of Valerian on insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Med. 2010;11(6):505-11. PMID 20347389
- Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 2013;8(5):e63773. PMID 23691095
- Ghazizadeh J, Sadigh-Eteghad S, Marx W, et al. The effects of lemon balm (Melissa officinalis L.) on depression and anxiety in clinical trials: A systematic review and meta-analysis. Phytother Res. 2021;35(12):6690-6705. PMID 34449930
- Gomes T, Juurlink DN, Antoniou T, et al. Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study. PLoS Med. 2017;14(10):e1002396. PMID 28972983
- Hepsomali P, Groeger JA, Nishihira J, et al. Effects of Oral Gamma-Aminobutyric Acid (GABA) Administration on Stress and Sleep in Humans: A Systematic Review. Front Neurosci. 2020;14:923. PMID 33041752
- Hidese S, Ogawa S, Ota M, et al. Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial. Nutrients. 2019;11(10). PMID 31623400
- Hsieh RY, Huang IC, Chen C, et al. Effects of Oral Alpha-Lipoic Acid Treatment on Diabetic Polyneuropathy: A Meta-Analysis and Systematic Review. Nutrients. 2023;15(16). PMID 37630823
- Ishikawa H, Takeshima M, Ishikawa H, et al. Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review. Neuropsychopharmacol Rep. 2021;41(3):434-439. PMID 34382380
- Kasper S, Iglesias-García C, Schweizer E, et al. Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder. Int J Neuropsychopharmacol. 2014a;17(5):685-95. PMID 24351233
- Kasper S, Gastpar M, Müller WE, et al. Lavender oil preparation Silexan is effective in generalized anxiety disorder–a randomized, double-blind comparison to placebo and paroxetine. Int J Neuropsychopharmacol. 2014b;17(6):859-69. PMID 24456909
- Kuang X, Liu C, Guo X, et al. The combination effect of vitamin K and vitamin D on human bone quality: a meta-analysis of randomized controlled trials. Food Funct. 2020;11(4):3280-3297. PMID 32219282
- Lang-Illievich K, Klivinyi C, Lasser C, et al. Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials. Nutrients. 2023;15(6). PMID 36986081
- Liao Y, Xie B, Zhang H, et al. Efficacy of omega-3 PUFAs in depression: A meta-analysis. Transl Psychiatry. 2019;9(1):190. PMID 31383846
- Mah J, Pitre T. Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis. BMC Complement Med Ther. 2021;21(1):125. PMID 33865376
- Mahmoudi R, Mohammadi-Sartang M, Servatyari K, et al. Effect of saffron on depression, anxiety and mood disorder: a GRADE assessed systematic review and meta-analysis of 34 randomized controlled trials. Nutr Neurosci. 2026;29(7):816-837. PMID 41693488
- Mersfelder TL, Nichols WH. Gabapentin: Abuse, Dependence, and Withdrawal. Ann Pharmacother. 2016;50(3):229-33. PMID 26721643
- Mikola T, Marx W, Lane MM, et al. The effect of vitamin D supplementation on depressive symptoms in adults: A systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2023;63(33):11784-11801. PMID 35816192
- Mukai T, Kishi T, Matsuda Y, et al. A meta-analysis of inositol for depression and anxiety disorders. Hum Psychopharmacol. 2014;29(1):55-63. PMID 24424706
- Möller HJ, Volz HP, Dienel A, et al. Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials. Eur Arch Psychiatry Clin Neurosci. 2019;269(2):183-193. PMID 29150713
- Pittenger C, Desan PH. Gabapentin abuse, and delirium tremens upon gabapentin withdrawal. J Clin Psychiatry. 2007;68(3):483-4. PMID 17388722
- Rolim LC, da Silva EM, Flumignan RL, et al. Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy. Cochrane Database Syst Rev. 2019;6(6):CD011265. PMID 31201734
- Rosebush PI, MacQueen GM, Mazurek MF. Catatonia following gabapentin withdrawal. J Clin Psychopharmacol. 1999;19(2):188-9. PMID 10211925
- Sarris J, Byrne GJ, Bousman CA, et al. Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study. Aust N Z J Psychiatry. 2020;54(3):288-297. PMID 31813230
- See S, Hendriks E, Hsiung L. Akathisia induced by gabapentin withdrawal. Ann Pharmacother. 2011;45(6):e31. PMID 21652784
- Shaw K, Turner J, Del Mar C. Are tryptophan and 5-hydroxytryptophan effective treatments for depression? A meta-analysis. Aust N Z J Psychiatry. 2002;36(4):488-91. PMID 12169147
- Skalny AV, Aschner M, Tsatsakis A, et al. Role of vitamins beyond vitamin D3 in bone health and osteoporosis (Review). Int J Mol Med. 2024;53(1):9. PMID 38063255
- Su KP, Tseng PT, Lin PY, et al. Association of Use of Omega-3 Polyunsaturated Fatty Acids With Changes in Severity of Anxiety Symptoms: A Systematic Review and Meta-analysis. JAMA Netw Open. 2018;1(5):e182327. PMID 30646157
- Swanson L, Fontana RJ. The contemporary epidemiology, causes, and management of drug-induced liver injury. Hepatol Commun. 2026;10(8). PMID 42475234
- Tran KT, Hranicky D, Lark T, et al. Gabapentin withdrawal syndrome in the presence of a taper. Bipolar Disord. 2005;7(3):302-4. PMID 15898970
- Trotti LM, Becker LA. Iron for the treatment of restless legs syndrome. Cochrane Database Syst Rev. 2019;1(1):CD007834. PMID 30609006
- Viljoen E, Visser J, Koen N, et al. A systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting. Nutr J. 2014;13:20. PMID 24642205
- Weleff J, Kovacevich A, Burson J, et al. Clinical Presentations and Treatment of Phenibut Toxicity and Withdrawal: A Systematic Literature Review. J Addict Med. 2023;17(4):407-417. PMID 37579098
- Winkelman JW, Wipper B. Restless Legs Syndrome: A Review. JAMA. 2026;335(8):703-714. PMID 41563785
- Yagi T, Naito T, Mino Y, et al. Impact of concomitant antacid administration on gabapentin plasma exposure and oral bioavailability in healthy adult subjects. Drug Metab Pharmacokinet. 2012;27(2):248-54. PMID 22240839
- Yosaee S, Clark CCT, Keshtkaran Z, et al. Zinc in depression: From development to treatment: A comparative/ dose response meta-analysis of observational studies and randomized controlled trials. Gen Hosp Psychiatry. 2022;74:110-117. PMID 32829928